Investigation of chiral active substances

This guideline applies to human and veterinary medicines.

Current effective version

Adopted guideline

Reference number3CC29A
Effective from01/04/1994
KeywordsChirality, stereogenic centre, isomerism, stereoisomers, enantiomer, diastereoisomers, racemat
DescriptionThis document intends to explain the requirements for studies of chiral active substances during the development of a medicinal product. It considers active substances with one or more stereogenic centres which display chirality but not constitutional isomerism or cis/trans isomerism.

Related content for human medicines

Related content for veterinary medicines

How useful was this page?

Add your rating